March 23, 2021
Solid Biosciences (SLDB) closed 25 million share offering at $5.75
February 17, 2021
Caladrius Biosciences (CLBS) closes $65 M RDO (registered direct offering)
February 2, 2021
Pluristem (PSTI) proposes 4.76 M Registered Direct Offering (RDO) priced at $6.30
January 28, 2021
Applied Genetic Technologies (AGTC) prices 16.741 M share offering and warrants at $4.45
January 26, 2021
Precigen (PGEN) closes 17.25 M share offering at $7.50
January 25, 2021
Caladrius Biosciences (CLBS) closes $25 M Private Placement of 12.5 M shares plus warrants at a purchase price of $2.00
January 19, 2021
Editas Medicine (EDIT) proposes 3.5 million shares offering
January 12, 2021
REGENXBIO (RGNX) closes 4.26 million share offering at $47.00
January 6, 2021
Fate Therapeutics (FATE) prices 4.42 million share offering at $85.50 per share
December 15, 2020
Cellectis S.A. (CLLS) cancels $100 M ADS (American Depositary Shares) offering
December 11, 2020
Solid Biosciences (SLDB) executes a $90 M Private Placement
December 2, 2020
Intellia Therapeutics (NTLA) prices 4.79 million share offering at $36.50
November 4, 2020
Bellicum Pharmaceuticals (BLCM) closes 1.04 M share offering
August 12, 2020
Adverum Biotechnologies (ADVM) closes $216.8 million offering priced at $3.00
July 8, 2020
BioLife Solutions (BLFS) closes 5.95 million share offering priced at $14.50
July 2, 2020
MiMedx Group (OTC PINK: MDXG closed $150 million private equity and debt financings
June 26, 2020
Editas Medicine (EDIT) closes 6.9 million shares offering at $31.25
June 11, 2020
Fate Therapeutics (FATE) completes 7,108 M share offering at $28.31 for proceeds of $201.3 million
June 6, 2020
Intellia Therapeutics (NTLA) closes $115 million offering
May 26, 2020
Caladrius Biosciences, Inc. (CLBS) closes RDO (registered direct offering) of 2.084 million shares priced at $2.06
May 19, 2020
bluebird bio (BLUE) proposes 9.09 M share offering priced at $55.00
May 13, 2020
Mesoblast (MESO ASX: MSB) completes US$90 M private placement of 43 M shares
March 6, 2020
BrainStorm Cell Therapeutics (BCLI) $10 M registered direct offering (RDO) priced at $8.00
February 28, 2020
Verastem (VSTM) offers 46.5 M private placement priced at $2.15 valued at $100 M to institutional investors
August 19, 2019
Bellicum Pharmaceuticals (BLCM) prices 575 K preferred stock share and warrant offering at of $100.00
4 hours 11 min ago
RegMed Investors’ (RMi) pre-open: Occam’s Razor
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors